China approves first hormone replacement therapy for hypoparathyroidism

Clinical Trial Phase |  News | 0 Comment | 04 Jun, 2021

On account of World Hypopara Awareness Day on June 1st, VISEN Pharmaceuticals, a biotech company focused on developing a...Read more

GlobalData reports the status of Global COVID-19 vaccine trials

Clinical Trial Phase |  Analysis | 0 Comment | 08 Feb, 2021

While governments are ramping up vaccination programs, continued research into the effectiveness of the vaccines is impe...Read more

I-Mab reports efficacy of Anti-CD47 monoclonal Ab on relapsed/refractory malignancy

Clinical Trial Phase |  Company results | 0 Comment | 25 Nov, 2020

I-Mab, a global clinical-stage biopharmaceutical company based in China and the US and committed to the discovery, devel...Read more

Gilead’s Biktarvy sustains viral suppression and tolerability in Asian HIV patients

Clinical Trial Phase |  News | 0 Comment | 16 Oct, 2020

Gilead Sciences, Inc. on 15 Oct 2020 announced findings from multiple studies in Asian population that evaluated th...Read more